PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.\', \'Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.\', \'Emergency Department, Padua University Hospital, Padua, Italy.\', \'Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.\', \'Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine Rochester, MN, USA.\', \'Department of Directional Hospital Management, Azienda Ospedale Università Padova , Padua, Italy.\', \'Department of Laboratory Medicine, University Hospital of Padova, Padova, Italy; Department of Medicine-DIMED, Medical School, University of Padova, Padova, Italy.\', \'Department of Medicine-DIMED, Medical School, University of Padova, Padova, Italy.\', \'Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Electronic address: jaffe.allan@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0009-9120(21)00022-910.1016/j.clinbiochem.2021.01.006
?:hasPublicationType
?:journal
  • Clinical biochemistry
is ?:pmid of
?:pmid
?:pmid
  • 33529580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all